DeuterOncology NV is a Liege based clinical stage biotechnology company that was founded in September 2020 by Dr Timothy Perera. The company is currently focused on the clinical development of a highly selective brain penetrant, deuterated MET kinase inhibitor DO-2.
Company Details
- Employees
- 4
- Founded
- -
- Address
- Clos Chanmurly 13, Liège,walloon Region 4000,belgium
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Website
- http://www.deuteroncology.com
- HQ
- Liège, Walloon Region
Deuteroncology Nv Questions
Deuteroncology Nv's website is http://www.deuteroncology.com
Deuteroncology Nv's LinkedIn profile is https://be.linkedin.com/company/deuteroncology
Deuteroncology Nv has
4 employees.
View email and phone details for 4
employees at Deuteroncology Nv.
Deuteroncology Nv's industry is
Biotechnology Research
Deuteroncology Nv's top competitors are
Celyad Oncology,
Hyloris Pharmaceuticals,
Amyl Therapeutics,
Conveyxo,
Exo Biologics,
Esobiotec,
Abscint,
Estetra,
Theratrame,
Inhatarget Therapeutics.
Deuteroncology Nv's categories are Biotechnology Research
Deuteroncology Nv's founding year is 2020
